Webinar: Extending monopolies: evidence from Brazil and Europe on the impact on innovation and access to medicines, June 25

18 June, 2020

Dear Neil & HIFA members,

I'm sharing this message from Marcela Vieira on her behalf, with permission.

I gather that the webinar is open to anyone that might be interested.

Julie

Dear all,

We would like to invite you to the next webinar of the series organized by the Knowledge Network for Innovation and Access to Medicines, a project of the Global Health Centre at the Graduate Institute of Geneva, which will take place on Thursday, June 25, 4pm - 5pm CEST / 11h-12h BRT.

We hope you will be able to join us for this discussion. The webinar will be recorded and made available a few days after it takes place. A list of the previous webinars of the series and their recordings and related materials is available at: https://www.knowledgeportalia.org/webinars

-----------------------------

Extending monopolies: evidence from Brazil and Europe on the impact on innovation and access to medicines

Thursday, June 25, 4pm - 5pm CEST / 11h-12h BRT

To join the webinar, please register here: https://us02web.zoom.us/webinar/register/8815924685746/WN_yxdxrxSBTCycTk...

Speakers:

- Julia Paranhos, Associate Professor, Economics Institute of the Federal University of Rio de Janeiro

- Ellen ‘t Hoen, Director, Medicines Law & Policy

Papers:

- Paranhos, J.; Mercadante, E.; Hasenclever, L. O custo para o SUS da extensão da vigência de patentes de medicamentos. Cadernos de Saúde Pública, forthcoming. Executive summary in English (Public health system increasing costs due to the extension of drug patents terms: https://drive.google.com/file/d/13jviVvVvMcsagACpcnVTEDT2WdxSJKA7/view

- ‘t Hoen Ellen et al., EU Review of Pharmaceutical Incentives: Suggestions for Change. Medicines Law and Policy, 2019. https://medicineslawandpolicy.org/useful-resources/briefs/

Exclusivity rights, such as patents, data exclusivity and other forms of market exclusivities, have been used as an incentive to promote pharmaceutical innovation by granting temporary monopolies over innovations. However, they have often resulted in high medicine prices and have not necessarily led to the health-needed innovations they were meant to incentivize.

Julia Paranhos will present a study on the costs of patent term extensions to the public health system in Brazil and implications for ongoing policy and judicial discussions. She will discuss a case in the Brazilian Supreme Court challenging the constitutionality of such extensions in light of the public interest. Ellen ‘t Hoen will present a study on how market exclusivities have affected access to medicines and innovation in Europe. She will offer recommendations for changes to current policies on Supplementary Protection Certificates, Data Exclusivity, and Orphan Medicinal Product regulations.

The webinar is free and open to the public and will be held in English. Participants will be able to pose questions orally or in writing, and the speakers will respond to a selection of these during the second half of the event. Recordings of all webinars will be made available afterward at the Knowledge Portal on Innovation and Access to Medicines, a project of the Global Health Centre, Graduate Institute of Geneva. After registering, you will receive a confirmation email with additional information on how to join the webinar using the Zoom platform. You can sign up to receive our newsletter by selecting the “global health box” at https://graduateinstitute.ch/newsletter.

---

Marcela Vieira

Researcher and Project Coordinator of the

Knowledge Network for Innovation and Access to Medicines

https://www.knowledgeportalia.org/

Global Health Centre, Research

Graduate Institute of International and Development Studies

http://www.graduateinstitute.ch/globalhealth

HIFA profile: Julie N Reza is a UK-based specialist in communications for biosciences, global health & international development (www.globalbiomedia.co.uk). She predominantly works with NGOs and not-for-profit organisations. Previously she was the senior science editor at TDR, based at the World Health Organization (WHO) in Geneva; prior to this she worked at the Wellcome Trust, UK, leading educational projects on international health topics including trypanosomiasis and trachoma. She has a PhD in immunology and a specialist degree in science communication. She also has several years research and postgraduate teaching experience. She is a member of the HIFA Steering Group and HIFA Social Media Working Group. www.hifa.org/people/steering-group

www.hifa.org/people/social-media

www.hifa.org/support/members/julie

Email: naimareza AT hotmail.com